Suicide-related events among child and adolescent patients during short-term antidepressant therapy

Psychiatry and Clinical Neurosciences

Volumn 65, Issue 3, 2011, Pages 239-245

  Kuba, Teizo ^a   Yakushi, Takashi ^a   Fukuhara, Hiroshi ^a   Nakamoto, Yuzuru ^a   Singeo Jr , Singeru Travis ^a   Tanaka, Osamu ^a   Kondo, Tsuyoshi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

antidepressant; baseline background; child and adolescent psychiatry; prediction; suicide related events

Indexed keywords

ANXIOLYTIC AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TETRACYCLIC ANTIDEPRESSANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ARTICLE; AUTOMUTILATION; CHILD; DIAGNOSTIC TEST ACCURACY STUDY; DISCRIMINANT ANALYSIS; DISEASE SEVERITY; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SHORT COURSE THERAPY; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT;

ADOLESCENT; ANTIDEPRESSIVE AGENTS; CHILD; FEMALE; HUMANS; MALE; MENTAL DISORDERS; RISK FACTORS; SELF MUTILATION; SEVERITY OF ILLNESS INDEX; SEX CHARACTERISTICS; SUICIDE; YOUNG ADULT;

EID: 79955068212     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2011.02204.x     Document Type: Article

References (35)

1. Grunebaum MF, Ellis SP, Li S, Oquendo MA, Mann JJ,. Antidepressants and suicide risk in the United States, 1985-1999. J. Clin. Psychiatry 2004; 65: 1456-1462.
2. Nakagawa A, Grunebaum MF, Ellis SP, et al,. Association of suicide and antidepressant prescription rates in Japan, 1999-2003. J. Clin. Psychiatry 2007; 68: 908-916. (Pubitemid 47015491)
3. Ludwig J, Marcotte DE,. Anti-depressants, suicide, and drug regulation. J. Policy Anal. Manage. 2005; 24: 249-272. (Pubitemid 40465774)
4. Children and Adolescents and Depression. National Alliance on Mental Illness. 2009; October(800). 1-3. Available from URL:.
5. Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E,. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 2004; 363: 1341-1345. (Pubitemid 38529872)
6. Stone M, Laughren T, Jones ML, et al,. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ 2009; 339: 1-10.
7. Gunnell D, Saperia J, Ashby D,. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ 2005; 330: 1-5.
8. Tiihonen J, Lönnqvist J, Wahlbeck K, Klaukka T, Tanskanen A, Haukka J,. Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch. Gen. Psychiatry 2006; 63: 1358-1367. (Pubitemid 44878519)
9. Simon GE, Savarino J, Operskalski B, Wang PS,. Suicide risk during antidepressant treatment. Am. J. Psychiatry 2006; 163: 41-47.
10. Dubicka B, Hadley S, Roberts C,. Suicidal behaviour in youths with depression treated with new-generation antidepressants: meta-analysis. Br. J. Psychiatry 2006; 189: 393-398. (Pubitemid 44683169)
11. Hammad TA, Laughren T, Racoosin J,. Suicidality in pediatric patients treated with antidepressant drugs. Arch. Gen. Psychiatry 2006; 63: 332-339. (Pubitemid 43345358)
12. Apter A, Lipschitz A, Fong R, et al,. Evaluation of suicidal thoughts and behaviors in children and adolescents taking paroxetine. J. Child Adolesc. Psychopharmacol. 2006; 16: 77-90.
13. Jick H, Kaye JA, Jick SS,. Antidepressants and the risk of suicidal behaviors. JAMA 2004; 292: 338-343. (Pubitemid 38944257)
14. Vitiello B, Silva S, Rohde P, et al,. Suicidal events in the treatment for adolescents with depression study (TAD). J. Clin. Psychiatry 2009; 70: 741-747.
15. Inagaki A, Inada T,. Dose equivalence of psychotropic drugs. Part X VIII. Dose equivalence of psychotropic drugs. 2006-Version. Jpn. J. Clin. Psychopharmacol. 2006; 9: 1443-1447 (in Japanese).
16. Wagner KD, Emslie GJ, Kawatch RA, Weller EB,. An update on depression in children and adolescents. J. Clin. Psychiatry 2008; 69: 1818-1828.
17. Bridge JA, Goldstein TR, Brent DA,. Adolescent suicide and suicidal behavior. J. Child Psychol. Psychiatry 2006; 47: 372-394. (Pubitemid 43356064)
18. Fergusson D, Doucette S, Glass KC, et al,. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trial. BMJ 2005; 330: 1-7.
19. Bridge JA, Iyengar S, Salary CB, et al,. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 2007; 297: 1683-1696.
20. Emslie GJ, Kennard BD, Mayes TL, et al,. Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. Am. J. Psychiatry 2008; 165: 459-467. (Pubitemid 351694289)
21. March J, Silva S, Petrycki S, et al,. The Treatment for Adolescents with Depression Study (TADS): long-term effectiveness and safety outcomes. Arch. Gen. Psychiatry 2007; 64: 1132-1144. (Pubitemid 47529337)
22. Joiner TE, Rudd MD, Rouleau MR, Wagner KD,. Parameters of suicidal crises vary as a function of previous suicide attempts in youth inpatients. J. Am. Acad. Child Adolesc. Psychiatry 2000; 39: 876-880. (Pubitemid 30429919)
23. Miranda R, Scott M, Hicks R, Wilcox HC, Harris Munfakh JL, Shaffer D,. Suicide attempt characteristics, diagnoses, and future attempts: comparing multiple attempters to single attempters and ideators. J. Am. Acad. Child Adolesc. Psychiatry 2008; 47: 32-40.
24. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn revised. American Psychiatric Association, Washington, DC, 2000.
25. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. World Health Organization, Geneva, 1992.
26. Dumais A, Lesage AD, Alda M, et al,. Risk factors for suicide completion in major depression: a case-control study of impulsive and aggressive behaviors in men. Am. J. Psychiatry 2005; 162: 2116-2124. (Pubitemid 41598266)
27. Brezo J, Paris J, Turecki G,. Personality traits as correlates of suicidal ideation, suicide attempts, and suicide completions: a systematic review. Acta Psychiatr. Scand. 2006; 113: 180-206. (Pubitemid 43340872)
28. Lester D, Lindsley LK,. Inward and outward irritability in the suicidally inclined. J. Gen. Psychol. 1988; 115: 37-39.
29. Nock MK, Kazdin AE,. Examination of affective, cognitive, and behavioral factors and suicide-related outcomes in children and young adolescents. J. Clin. Child Adolesc. Psychol. 2002; 31: 48-58. (Pubitemid 37110139)
30. Nordström P, Schalling D, Asberg M,. Temperamental vulnerability in attempted suicide. Acta Psychiatr. Scand. 1995; 92: 155-160.
31. Johnson J, Horwath E, Weissman MM,. The validity of major depression with psychotic features based on a community study. Arch. Gen. Psychiatry 1991; 48: 1075-1081.
32. Suominen K, Haukka J, Valtonen HM, Lönnqvist J,. Outcome of patients with major depressive disorder after serious suicide attempt. J. Clin. Psychiatry 2009; 70: 1372-1378.
33. Brent DA, Baugher M, Bridge J, Chen T, Chiappetta L,. Age- and sex-related risk factors for adolescent suicide. J. Am. Acad. Child Adolesc. Psychiatry 1999; 38: 1497-1505.
34. Linehan MM, Comtois KA, Murray AM, et al,. Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch. Gen. Psychiatry 2006; 63: 757-766.
35. Mufson L, Dorta KP, Wickramaratne P, Nomura Y, Olfson M, Weissman MM,. A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents. Arch. Gen. Psychiatry 2004; 61: 577-584. (Pubitemid 38747312)